FDA Inspection 799168 — Mylan Pharmaceuticals Inc.

Mylan Pharmaceuticals Inc. — FEI 3007886374

The FDA completed an inspection of Mylan Pharmaceuticals Inc. on September 27, 2012 in San Carlos, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2012
Fiscal Year
2012
Product Type
Devices
Project Area
Compliance: Devices
Location
San Carlos, CA (United States)